Impaired Cholesterol-Uptake Capacity of HDL Might Promote Target-Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation

• Published in: Journal of the American Heart Association Vol. 8; no. 9; p. e011975
• Main Authors: Nagano, Yuichiro, Otake, Hiromasa, Toba, Takayoshi, Kuroda, Koji, Shinkura, Yuto, Tahara, Natsuko, Tsukiyama, Yoshiro, Yanaka, Kenichi, Yamamoto, Hiroyuki, Nagasawa, Akira, Onishi, Hiroyuki, Sugizaki, Yoichiro, Takeshige, Ryo, Harada, Amane, Murakami, Katsuhiro, Kiriyama, Maria, Oshita, Toshihiko, Irino, Yasuhiro, Kawamori, Hiroyuki, Ishida, Tatsuro, Toh, Ryuji, Shinke, Toshiro, Hirata, Ken-Ichi
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 07-05-2019; Wiley
• Subjects: Aged; Aged, 80 and over; Cholesterol, HDL - blood; cholesterol‐uptake capacity; Coronary Artery Disease - blood; Coronary Artery Disease - diagnostic imaging; Coronary Artery Disease - therapy; Coronary Vessels - diagnostic imaging; Coronary Vessels - metabolism; Female; high‐density lipoprotein; Humans; Macrophages - metabolism; Male; Middle Aged; neoatherosclerosis; optical coherence tomography; Original Research; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - instrumentation; Plaque, Atherosclerotic; Registries; Stents; target‐lesion revascularization; Time Factors; Tomography, Optical Coherence; Treatment Outcome; cholesterol‐uptake capacity; high‐density lipoprotein; optical coherence tomography; neoatherosclerosis; target‐lesion revascularization
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/jaha.119.011975

Background We evaluated the importance of high-density lipoprotein (HDL) functionality for target-lesion revascularization in patients treated with coronary stents using a rapid cell-free assay system to evaluate the functional capacity of HDL to accept additional cholesterol (cholesterol-uptake capacity; CUC). Methods and Results From an optical coherence tomography (OCT) registry of patients treated with coronary stents, 207 patients were enrolled and their HDL was functionally evaluated by measuring the CUC. Follow-up OCT was performed (median duration, 24.5 months after stenting) to evaluate the presence of neoatherosclerosis. Clinical follow-up was performed to assess target-lesion revascularization for a median duration of 42.3 months after stent implantation. Neoatherosclerosis was identified in 37 patients (17.9%). Multivariate logistic regression analysis revealed that a decreased CUC was independently associated with neoatherosclerosis (odds ratio, 0.799; P<0.001). The CUC showed a significant inverse correlation with incidence of target-lesion revascularization (odds ratio, 0.887; P=0.003) and with lipid accumulation inside stents, suggesting that neoatherosclerosis contributes to the association between CUC and target-lesion revascularization. Conclusions Impaired HDL functionality, detected as decreased CUC, might lead to future stent failure by provoking atherogenic changes of the neointima within stents. Both quantitative and qualitative assessments of HDL might enable the improved prediction of clinical outcomes after stent implantation.